Supply of Evinacumab (Evkeeza) injectable solution

Summary

The open procurement concerns the supply of injectable Evinacumab (Evkeeza) solution, classified as a cardiovascular medicine. The estimated contract value is EUR 698,057. Offers must be submitted by 25 September 2026. The machine-readable notice did not provide precise qualification, compliance or exclusion requirements; these must be checked in the official tender details and documents.